Evidence shows not to retreat Hep C non-responders or relapsers with only interferon. @CochraneLibrary @LiverHealthy http://t.co/LlOWqQu0
RT @cochranecollab: Updated #Cochrane Review | Is #interferon beneficial or harmful in retreatment of #hepatitis C? | http://t.co/ZCvzzfWK
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C Updated http://t.co/9Owu2BJA
RT @cochranecollab: Updated #Cochrane Review | Is #interferon beneficial or harmful in retreatment of #hepatitis C? | http://t.co/ZCvzzfWK
RT @cochranecollab: Updated #Cochrane Review | Is #interferon beneficial or harmful in retreatment of #hepatitis C? | http://t.co/lDPh7u7B
RT @cochranecollab: Updated #Cochrane Review | Is #interferon beneficial or harmful in retreatment of #hepatitis C? | http://t.co/ZCvzzfWK
Updated #Cochrane Review | Is #interferon beneficial or harmful in retreatment of #hepatitis C? | http://t.co/ZCvzzfWK
Interferon for interferon nonresponding and relapsing patients with HCV rarely helps, may raise risk of death http://t.co/aorxqNHr
MT @davidtovey: #Cochrane Review shows concerns about re-use of interferon and reliance on liver markers in Hep C http://t.co/JzjmLDr4
MT @davidtovey: #Cochrane Review shows concerns about re-use of interferon and reliance on liver markers in Hep C http://t.co/JzjmLDr4
Cochrane Review shows concerns about re-use of interferon and reliance on liver markers in Hep C @CochraneLibrary http://t.co/F7FtmIWZ